A kit and method for closed-tube visualization detection of Staphylococcus aureus

CN117165697BActive Publication Date: 2026-08-14CHINA JILIANG UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-01-09
Publication Date
2026-08-14

AI Technical Summary

Technical Problem

但是由于CRISPR-Cas12系统酶对温度比较敏感,通常菌株特异性片段扩增步骤与CRISPR-Cas12系统在不同反应温度下进行,导致需要多次开管加样过程,引起气溶胶污染造成假阳性

Benefits of technology

[0029]与现有技术相比,本发明方法可以不需要任何检测观察仪器的辅助,在闭管条件下实现金黄色葡萄球菌S.aureus的检测。本发明通过保护DNA链的设计,设计的保护DNA链前16个碱基序列与crRNA特异性序列的16个碱基进行碱基互补配对,在特定条件下与crRNA互补配对形成DNA-crRNA复合体,从而抑制CRISPR体系的反应。保护DNA链后8个碱基为能在解链后与5’端前8个碱基互补配对形成茎环结构,防止DNA链与crRNA再次结合。DNA-crRNA复合体的存在使得RPA体系在总体系中单独反应完全,本发明将RPA体系和CRISPR体系混合后置于管底,金纳米颗粒置于管盖上,将体系在37℃下反应后,DNA-crRNA复合体会逐渐发生解链并释放crRNA,DNA链变成茎环结构并保证防止在解链后再与crRNA互补形成复合体。管底体系37℃反应一定后将管盖的Au-DNA1/Au-DNA2甩下与RPA-CRISPR体系混合,观察颜色反应变化,由此形成闭管检测体系防止交叉污染的产生。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117165697B_ABST
    Figure CN117165697B_ABST
Patent Text Reader

Abstract

This invention discloses a kit and method for closed-tube visualization detection of Staphylococcus aureus. The kit comprises a mixed reaction system within a detection tube and thiol-modified gold nanoparticles on the tube cap. The mixed reaction system contains a mixture of RPA amplification and a protective CRISPR / Cas12a reaction system. The thiol-modified gold nanoparticle mixture on the tube cap can be added to the mixed reaction system while the tube is closed. This invention, through the design of a DNA-crRNA complex, places the RPA system, CRISPR system, and gold nanoparticles in the same tube, forming a closed-tube detection system to prevent cross-contamination. This invention allows for integrated closed-tube detection of Staphylococcus aureus by visually observing color changes without relying on any instruments.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the fields of biology and chemistry, and specifically relates to a kit and method for closed-tube visualization detection of Staphylococcus aureus. Background Technology

[0002] In recent years, the frequency of foodborne illness events has been increasing, and foodborne illness has become one of the most widespread public health problems in the world today. With the continuous development of express delivery and food delivery platforms, food can be transmitted during transportation, leading to various food quality problems caused by foodborne pathogens and increasing the risk of foodborne disease outbreaks. Staphylococcus aureus (S. aureus), also known as "Gram-positive bacteria," belongs to the genus Staphylococcus and is a common foodborne pathogen. Its optimal growth temperature is 37℃, pH 7.4, and it is tolerant of high salt concentrations, growing in environments with salt concentrations approaching 10%. Staphylococcus aureus commonly resides on the skin, nasal cavity, throat, gastrointestinal tract, boils, and abscesses of humans and animals, and is also ubiquitous in the air and sewage. Dairy products and meat are major breeding grounds for Staphylococcus aureus, posing a significant threat to human health. Therefore, rapid detection of Staphylococcus aureus in food has become an important means of protecting public health.

[0003] Currently, detection techniques for Staphylococcus aureus (S. aureus) mainly include plate culture, MPN counting, and PCR amplification. These methods are time-consuming, prone to contamination leading to false positives, and can introduce pathogens into the environment, posing a threat to human health. Immunological methods rely on the specific reaction between antigens and antibodies, such as enzyme-linked immunosorbent assay (ELISA). While these methods offer high specificity, they have low sensitivity, are time-consuming, costly, require professional operation, and depend on large instruments for result observation. Temperature-dependent or isothermal nucleic acid amplification techniques, such as PCR amplification, polymerase chain reaction (RPA), multiplex RPA, quantitative real-time RPA, and loop-mediated isothermal amplification (LAMP), all require large instruments for result observation and cannot provide direct visualization. Therefore, developing a time-saving, labor-saving, low-cost, and accurate one-step detection method has become a major research direction.

[0004] Clustered regularly interspaced short palindromic repeats (CRISPR) are an immune mechanism in many bacteria and archaea to combat invasion. In nature, a fierce competition for survival exists between bacteria / archaea and bacteriophages. To resist invasion by foreign bacteriophages, bacteria and archaea have evolved the CRISPR-Cas system to recognize and cleave invading nucleic acids, thus protecting themselves. Cas12a is a type 2 V Cas protein. When inactive, it has no cleavage activity. When it binds to specific crRNA, Cas12a undergoes a conformational change, forming a Cas12a-crRNA binary complex. This complex specifically recognizes target DNA and activates its endonuclease activity. After Cas12a sequentially cleaves the DNA double strand in a cis-cleavage manner, this active site remains exposed, exhibiting trans-cleavage activity and non-specifically cleaving the surrounding ssDNA. Scientists have designed various highly sensitive and specific nucleic acid detection platforms to leverage the characteristics of Cas12a, and are also continuously developing portable, low-cost, and rapid detection platforms that do not require large instruments. However, because the CRISPR-Cas12 enzyme is highly temperature-sensitive, the amplification step of strain-specific fragments is usually performed at different reaction temperatures than the CRISPR-Cas12 system, requiring multiple tube opening and sample loading processes, which can lead to aerosol contamination and false positives. Furthermore, the fluorescence generated by Cas12 protein cleaving DNA probes requires specialized instruments for observation, further increasing detection costs. Therefore, a closed-tube visualization detection system is needed. Summary of the Invention

[0005] The purpose of this invention is to overcome the technical deficiencies of traditional Staphylococcus aureus (S. aureus) detection methods by using specific gene fragments as detection targets, and to provide a kit and method for closed-tube visualization detection of S. aureus.

[0006] Therefore, the technical solution adopted by the present invention is as follows:

[0007] This invention first provides a kit for closed-tube visualization detection of Staphylococcus aureus, which includes a mixed reaction system located inside the detection tube and a mixture of thiol DNA-modified gold nanoparticles located on the cap of the detection tube.

[0008] The mixed reaction system in the detection tube includes a mixed RPA amplification system and a CRISPR / Cas12a reaction system with protective DNA modification.

[0009] The RPA amplification system is used to amplify specific gene fragments in the genome of Staphylococcus aureus using RPA, and includes primer RPA-F, primer RPA-R, Primer-Free-Rbuffer, DNA template, RNAase-free water, and magnesium acetate.

[0010] The CRISPR / Cas12a reaction system comprises: Cas12a, a DNA-crRNA complex, a Linker-ssDNA, buffer C, and ddH2O. The DNA-crRNA complex is formed by the pairing of a protective DNA strand with crRNA. It can unwind at 37°C and slowly release crRNA to bind to the target DNA on a specific gene fragment in the genome of Staphylococcus aureus. The sequence of the protective DNA strand is shown in SEQ ID No. 3, and the protective DNA is designed with a stem-loop structure. The first 16 bases of the protective DNA pair complementaryly with the 16 bases of the crRNA-specific sequence, and the last 8 bases, after unwinding, can complement the first 8 bases of the protective DNA strand to form a stem-loop structure. When the system reacts at 37°C for 10 minutes, the DNA-crRNA complex gradually unwinds, releasing crRNA. The DNA strand itself forms a stem-loop structure, preventing further complementarity with crRNA after unwinding to form a complex.

[0011] The gold nanoparticles modified with thiol DNA on the detection tube cap include Au NPs-DNA1, Au NPs-DNA2, and a saturated sodium chloride solution; wherein Au NPs-DNA1 and Au NPs-DNA2 are formed by modifying the gold nanoparticles with two different thiol DNA sequences, wherein the two thiol DNA sequences are complementary to the Linker-ssDNA in the mixed reaction system;

[0012] The mixture of thiol-DNA-modified gold nanoparticles on the tube cap is disposed on the lower surface of the tube cap, allowing it to be added to the mixed reaction system while the detection tube is closed.

[0013] As a preferred embodiment of the present invention, the volume of the in-tube mixing reaction system is equal to that of the mixture of gold nanoparticles modified with thiol DNA;

[0014] The total volume of the in-tube mixing reaction system was 10 μL, the RPA amplification system was 2.5 μL, and the CRISPR / Cas12a reaction system after DNA protection modification was 7.5 μL. The concentrations of each component were as follows: In the 2.5 μL RPA amplification system, primers RPA-F and RPA-R were 4.8 μM, magnesium acetate was 14 mM, primer-free-R buffer was 1.475 μL, DNA template was 0.1 μL, and RNAase-free water was 0.56 μL; In the 7.5 μL CRISPR / Cas12a reaction system, Cas12a was 250 nM, DNA-crRNA complex was 75 nM, and linker-ssDNA was 1 μM; the volume of buffer C added was 1 μL.

[0015] The buffer C is composed of the following components: 50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, and 1 mM MTT; the pH of buffer C is 7.9.

[0016] As a preferred embodiment of the present invention, the total volume of the gold nanoparticle mixture modified with thiol DNA is 10 μL, wherein the concentration of Au NPs-DNA1 is 2.7 μM and the concentration of Au NPs-DNA2 is 2.7 μM.

[0017] As a preferred embodiment of the present invention, the sequence of RPA-F is shown in SEQ ID No. 1, and the sequence of RPA-R is shown in SEQ ID No. 2.

[0018] As a preferred embodiment of the present invention, the sequence of the crRNA is shown in SEQ ID No. 4.

[0019] As a preferred embodiment of the present invention, the sequence of the Linker-ssDNA is shown in SEQ ID No. 5.

[0020] As a preferred embodiment of the present invention, the sequence of NPs-DNA1 is shown in SEQ ID No. 6; the sequence of NPs-DNA2 is shown in SEQ ID No. 7.

[0021] The sequences designed in this invention correspond as follows:

[0022]

[0023] The present invention also provides the application of the above-mentioned kit in the detection of Staphylococcus aureus.

[0024] The present invention also provides a method for closed-tube visualization detection of Staphylococcus aureus using the above-mentioned kit, which includes the following steps:

[0025] 1) Add the sample to be tested into the mixed reaction system in the tube, and perform RPA amplification of specific gene fragments in the genome of Staphylococcus aureus using the amplification primers in the reaction system at 37°C;

[0026] Simultaneously, the DNA-crRNA complex in the reaction system unwinds at 37°C and slowly releases crRNA to bind to the target DNA on the specific gene fragment; under the mediation of crRNA, Cas12a specifically recognizes the amplified fragment of the specific gene fragment and activates nuclease activity to cleave the Linker-ssDNA that complements the two thiol DNAs in the reaction system.

[0027] 2) After the reaction in step 1) is complete, add the thiol-DNA modified gold nanoparticle mixture to the system in the tube and observe the color change of the system with the naked eye. When the sample contains Staphylococcus aureus, the gold nanoparticles do not aggregate after Linker-ssDNA is cleaved, and the system is red. When the sample does not contain Staphylococcus aureus, the gold nanoparticles aggregate, and the red color of the system fades. This achieves closed-tube detection of Staphylococcus aureus.

[0028] As a preferred embodiment of the present invention, in step 2), after adding the mixture of gold nanoparticles modified with thiol DNA, the mixture is reacted for 5 minutes, then centrifuged, and the color change is observed.

[0029] Compared with existing technologies, the method of this invention can detect Staphylococcus aureus (S. aureus) under closed-tube conditions without the need for any detection or observation instruments. This invention utilizes a DNA strand protection design. The first 16 bases of the protected DNA strand are designed to pair complementaryly with the 16 bases of the crRNA-specific sequence. Under specific conditions, this complementary pairing forms a DNA-crRNA complex, thereby inhibiting the CRISPR reaction. The last 8 bases of the protected DNA strand are designed to pair complementaryly with the first 8 bases at the 5' end after unwinding, forming a stem-loop structure and preventing the DNA strand from rebinding to crRNA. The presence of the DNA-crRNA complex ensures that the RPA system reacts completely independently within the overall system. In this invention, the RPA and CRISPR systems are mixed and placed at the bottom of a tube, with gold nanoparticles placed on the tube cap. After reacting the system at 37°C, the DNA-crRNA complex gradually unwinds, releasing crRNA. The DNA strand forms a stem-loop structure, preventing further complementary formation of the complex with crRNA after unwinding. After the system at the bottom of the tube has reacted at 37°C for a certain period, the Au-DNA1 / Au-DNA2 from the tube cap is dropped off and mixed with the RPA-CRISPR system. The color reaction change is then observed, thus forming a closed-tube detection system to prevent cross-contamination. Attached Figure Description

[0030] Figure 1 This is a schematic diagram illustrating the working principle of the present invention.

[0031] Figure 2 This is a graph showing the results of the sensitivity test for closed-tube detection of Staphylococcus aureus (S. aureus) according to this invention.

[0032] Figure 3 This is a graph showing the results of the sensitivity detection of Staphylococcus aureus (S. aureus) in food samples using closed-tube methods according to the present invention.

[0033] Figure 4 This is a diagram showing the results of the detection specificity experiment of Staphylococcus aureus in this invention. Detailed Implementation

[0034] The present invention will be further described and illustrated below with reference to specific embodiments. The embodiments described are merely examples of the content of this disclosure and do not limit the scope of the invention. The technical features of each embodiment in the present invention can be combined accordingly, provided that there is no mutual conflict.

[0035] I. Visual Detection of Staphylococcus aureus using the CRISPR / Cas12a System

[0036] Reference Figure 1The procedure involved pretreating the actual samples using thermal lysis. Under aseptic conditions, 1 mL of the homogenized sample was transferred to a sterile centrifuge tube and centrifuged at 8000×g for 2 min, discarding the supernatant. The sample was resuspended in 200 μL of sterile deionized water, centrifuged at 8000×g for 2 min, and the supernatant was discarded. 100 μL of sterile deionized water was added, and the sample was boiled at 100℃ for 10 min and then cooled to serve as an RPA template for amplification. A protective DNA strand was designed, and the optimal fragment length of the protective DNA strand (i.e., SEQ ID No. 3) was selected by PAGE gel electrophoresis. The DNA strand was reacted with crRNA (i.e., SEQ ID No. 4) at 85℃ for 5 min, and the temperature was slowly reduced to 4℃ at a rate of 0.1℃ / s to obtain the DNA-crRNA complex.

[0037] The 2.5 μL RPA amplification system was constructed as follows: Primer RPA-F (SEQ ID No. 1) and primer RPA-R (SEQ ID No. 2) were at 4.8 μM each; magnesium acetate was at 14 mM; primer-free-R buffer was at 1.475 μL; DNA template was at 0.1 μL; and RNAase-free water was at 0.56 μL. A 7.5 μL CRISPR / Cas12a reaction system was constructed, including 250 nM Cas12a, 75 nM DNA-crRNA, 1 μM Linker-ssDNA (SEQ ID No. 4), 2.5 μL amplification product, and 1 μL buffer C (50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, 1 mM DTT, pH...). 7.9) Add RNase-free water to a final volume of 10 μL, and thoroughly mix the RPA and CRISPR systems at the bottom of the tube. Place 10 μL of Au-DNA1 / Au-DNA2 and an appropriate amount of saturated sodium chloride on the tube cap (Au NPs-DNA1 concentration is 2.7 μM, Au NPs-DNA2 concentration is 2.7 μM). Add the sample to be tested to the mixed reaction system in the tube and incubate at 37 °C for 40 min. After 40 min, shake off the gold nanoparticle mixture from the tube cap and mix it with the reaction system, then observe the colorimetric results.

[0038] II. Sensitivity Characterization of the Method for Detecting Staphylococcus aureus by the Invention

[0039] To investigate the detection sensitivity of this invention for Staphylococcus aureus (S. aureus) in DNA of different concentrations, DNA samples with different concentrations of S. aureus (42 pg / μL, 4.2 pg / μL, 420 fg / μL, 42 fg / μL, 4.2 fg / μL, 420 ag / μL, 42 ag / μL, and 4.2 ag / μL) were added to a mixed system containing RPA and CRISPR. The specific gene fragment system was analyzed using the closed-tube visualization detection method of the CRISPR / Cas12a system of this invention. Figure 2 In Part A, the effect of different DNA concentrations of *Staphylococcus aureus* on detection and the colorimetric results are shown. Part B shows the UV absorption peak diagram and error bar chart plotted for the sensitivity detection of *Staphylococcus aureus* with different DNA concentrations using a UV spectrophotometer and ELISA reader. *Staphylococcus aureus* with different concentrations (42 pg / μL, 4.2 pg / μL, 420 fg / μL, 42 fg / μL, 4.2 fg / μL, 420 ag / μL, 42 ag / μL, and 4.2 ag / μL) was amplified isothermally using RPA. The results were analyzed using a CRISPR / Cas12a visualization detection system. Visual observation showed that *Staphylococcus aureus* concentrations as low as 4.2 ag / μL were identified.

[0040] III. The method of the present invention for detecting Staphylococcus aureus in various food samples

[0041] The sensitivity of Staphylococcus aureus at different bacterial concentrations in eggs was detected using the CRISPR / Cas12a system with DNA protective strand and nanomaterial closed-tube visualization detection method. Figure 3 Figure A shows a colorimetric diagram of the sensitivity detection of Staphylococcus aureus (S. aureus) in eggs at different bacterial concentrations. Figure 3 Figure B demonstrates the sensitivity detection of Staphylococcus aureus (S. aureus) at different bacterial concentrations in eggs using a UV spectrophotometer and microplate reader, plotted as UV absorption peaks and error bar charts. Concentrations of 1×10⁻⁶ were used... 6 CFU / mL, 1×10 5 CFU / mL, 1×10 4 CFU / mL, 1×10 3 CFU / mL, 1×10 2 CFU / mL, 1×10 1 CFU / mL, 1×10 0CFU / mL of Staphylococcus aureus was added to an egg sample for pretreatment and followed by RPA isothermal amplification. Analysis was performed using a closed-tube visualization detection system based on the CRISPR / Cas12a protocol. Colorimetric results observed with the naked eye showed identification as low as 1×10⁻⁶. 0 Staphylococcus aureus at CFU / mL.

[0042] IV. Characterization of the Detection Specificity of the Method of the Invention

[0043] To characterize the specificity of the CRISPR / Cas12a system for detecting Staphylococcus aureus using a closed-tube visualization detection method based on DNA protection strands and nanomaterials, clinical isolates of Escherichia coli O157:H7, Vibrio parahaemolyticus (VP), Salmonella (Sal), Listeria monocytogenes (Lm), and Staphylococcus aureus (SA) were used as detection samples. Egg samples were pretreated, RPA amplified, and mixed with the CRISPR / Cas12a system in one tube. An equal volume of gold nanoprobe was added to the tube cap. The closed-tube visualization detection system was then analyzed, and colorimetric results were shown. Figure 4 As shown, naked-eye observation revealed a positive result for clinical isolates of Staphylococcus aureus (S. aureus); however, naked-eye observation of the specific systems for Vibrio parahaemolyticus, Listeria monocytogenes, Escherichia coli O157:H7, and Salmonella all showed negative results. This demonstrates that the CRISPR / Cas12a system, utilizing DNA protective strands and nanomaterials in a closed-tube visualization detection method, exhibits good accuracy and specificity.

[0044] The above-described embodiments are merely illustrative of several implementations of the present invention, and while the descriptions are specific and detailed, they should not be construed as limiting the scope of the present invention. Those skilled in the art can make various modifications and improvements without departing from the concept of the present invention, and these modifications and improvements all fall within the scope of protection of the present invention.

Claims

1. A kit for closed-tube visualization detection of Staphylococcus aureus, characterized in that... This includes a mixed reaction system located inside the detection tube and a mixture of thiol-DNA-modified gold nanoparticles located on the cap of the detection tube; The mixed reaction system in the detection tube includes a mixed RPA amplification system and a CRISPR / Cas12a reaction system with protective DNA modification. The RPA amplification system is used to amplify specific gene fragments in the Staphylococcus aureus genome using RPA, and includes primer RPA-F, primer RPA-R, Primer-Free-R buffer, DNA template, RNAase-free water, and magnesium acetate; the sequence of RPA-F is shown in SEQ ID No. 1, and the sequence of RPA-R is shown in SEQ ID No. 2; The CRISPR / Cas12a reaction system comprises: Cas12a, DNA-crRNA complex, Linker-ssDNA, buffer C, and ddH2O; the buffer C consists of the following components: 50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, and 1 mM MTT; the pH of the buffer C is 7.9; the sequence of the crRNA is shown in SEQ ID No.

4. The DNA-crRNA complex is formed by the pairing of a protective DNA strand and crRNA. It can unwind at 37 °C and slowly release crRNA, which can bind to target DNA on a specific gene fragment in Staphylococcus aureus. The sequence of the protective DNA strand is shown in SEQ ID No. 3, and the protective DNA is designed with a stem-loop structure. The first 16 bases of the 3' end of the protective DNA pair complementaryly with the 16 bases of the crRNA-specific sequence. The last 8 bases, after unwinding, can complement the first 8 bases of the protective DNA strand to form a stem-loop structure. When the system reacts at 37 °C for a certain time, the DNA-crRNA complex gradually unwinds and releases crRNA. The protective DNA strand itself forms a stem-loop structure, preventing it from forming a complex again after unwinding. The gold nanoparticles modified with thiol DNA on the detection tube cap include Au NPs-DNA1, Au NPs-DNA2, and a saturated sodium chloride solution; wherein Au NPs-DNA1 and Au NPs-DNA2 are formed by modifying the gold nanoparticles with two different thiol DNA sequences, wherein the two thiol DNA sequences are complementary to the Linker-ssDNA in the mixed reaction system; The mixture of thiol-DNA-modified gold nanoparticles on the tube cap is disposed on the lower surface of the tube cap, allowing it to be added to the mixed reaction system while the detection tube is closed.

2. The reagent kit according to claim 1, characterized in that, The volume of the in-tube mixing reaction system is equal to that of the thiol DNA-modified gold nanoparticle mixture. The total volume of the in-tube mixing reaction system was 10 μL, the RPA amplification system was 2.5 μL, and the CRISPR / Cas12a reaction system after DNA protection modification was 7.5 μL. The concentrations of each component were as follows: In the 2.5 μL RPA amplification system, the primers RPA-F and RPA-R were 4.8 μM each, the magnesium acetate was 14 mM, the primer-free-R buffer was 1.475 μL, the DNA template was 0.1 μL, and the RNAase-free water was 0.56 μL; In the 7.5 μL CRISPR / Cas12a reaction system, the Cas12a was 250 nM, the DNA-crRNA complex was 75 nM, and the linker-ssDNA was 1 μM; the volume of buffer C added was 1 μL.

3. The reagent kit according to claim 1, characterized in that, The total volume of the gold nanoparticle mixture modified with thiol DNA is 10 μL, wherein the concentration of Au NPs-DNA1 is 2.7 μM and the concentration of Au NPs-DNA2 is 2.7 μM.

4. The kit according to claim 1, characterized in that, The sequence of the Linker-ssDNA is shown in SEQ ID No.

5.

5. The kit according to claim 1, characterized in that, The sequence of Au NPs-DNA1 is shown in SEQ ID No. 6; the sequence of Au NPs-DNA2 is shown in SEQ ID No.

7.

6. The use of the kit according to any one of claims 1-5 in the detection of Staphylococcus aureus in food samples.

7. A method for closed-tube visual detection of Staphylococcus aureus in food samples based on the kit described in any one of claims 1-5, characterized in that... Includes the following steps: 1) Add the sample to be tested into the mixed reaction system in the tube. The amplification primers RPA-F and RPA-R in the reaction system amplify the specific gene fragment in the Staphylococcus aureus genome at 37 °C. Simultaneously, the DNA-crRNA complex in the reaction system unwinds at 37°C and slowly releases crRNA to bind to the target DNA on the specific gene fragment; under the mediation of crRNA, Cas12a specifically recognizes the amplified fragment of the specific gene fragment and activates nuclease activity to cleave the Linker-ssDNA that complements the two thiol DNAs in the reaction system. 2) After the reaction in step 1) is complete, add the mixture of gold nanoparticles modified with thiol DNA to the system in the tube and observe the color change of the system with the naked eye. When the sample contains Staphylococcus aureus, the gold nanoparticles do not aggregate after Linker-ssDNA is cleaved, and the system is red. When the sample does not contain Staphylococcus aureus, the gold nanoparticles aggregate, and the red color of the system fades. This achieves closed-tube detection of Staphylococcus aureus.

8. The method according to claim 7, characterized in that, In step 2), after adding the mixture of gold nanoparticles modified with thiol DNA, the mixture is reacted for 5 minutes, then centrifuged, and the color change is observed.

Citation Information

Patent Citations

  • Method for visually detecting staphylococcus aureus by using CRISPR / Cas12a system

    CN113667765A

  • One-pot RPA-CRISPR nucleic acid detection method and system based on light activation

    CN114703258A